BICO Group AB (publ) (BICO.ST)
SEK 34.84
(5.07%)
SEK 34.84
(5.07%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -618.3 Million SEK | -286.44% |
| 2021 | -160 Million SEK | -142.1% |
| 2020 | -66.08 Million SEK | -1660.47% |
| 2019 | -3.75 Million SEK | -1109.14% |
| 2018 | 372 Thousand SEK | 1717.39% |
| 2017 | -23 Thousand SEK | 0.0% |
| 2016 | - SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q2 | -955.5 Million SEK | -829.47% |
| 2023 Q3 | -62.8 Million SEK | 93.43% |
| 2023 Q1 | -102.8 Million SEK | 85.81% |
| 2022 Q3 | 184.1 Million SEK | 76.68% |
| 2022 Q2 | 104.2 Million SEK | 998.28% |
| 2022 Q1 | -11.6 Million SEK | 78.28% |
| 2022 FY | -618.3 Million SEK | -286.44% |
| 2022 Q4 | -724.3 Million SEK | -493.43% |
| 2021 FY | -160 Million SEK | -142.1% |
| 2021 Q2 | -31.4 Million SEK | 48.36% |
| 2021 Q3 | -91.3 Million SEK | -190.76% |
| 2021 Q4 | -53.4 Million SEK | 41.51% |
| 2021 Q1 | -60.8 Million SEK | 0.0% |
| 2020 Q1 | -20.01 Million SEK | -209.5% |
| 2020 FY | -66.08 Million SEK | -1660.47% |
| 2020 Q2 | -17.54 Million SEK | 12.32% |
| 2020 Q3 | -22.06 Million SEK | -25.73% |
| 2019 Q1 | 1.07 Million SEK | 58.53% |
| 2019 FY | -3.75 Million SEK | -1109.14% |
| 2019 Q2 | -569 Thousand SEK | -152.78% |
| 2019 Q4 | -6.46 Million SEK | -29.94% |
| 2019 Q3 | -4.97 Million SEK | -774.52% |
| 2018 Q4 | 680 Thousand SEK | 47.83% |
| 2018 FY | 372 Thousand SEK | 1717.39% |
| 2018 Q1 | 605 Thousand SEK | 226.3% |
| 2018 Q2 | 399 Thousand SEK | -34.05% |
| 2018 Q3 | 460 Thousand SEK | 15.29% |
| 2017 Q2 | -537 Thousand SEK | -690.11% |
| 2017 FY | -23 Thousand SEK | 0.0% |
| 2017 Q1 | 91 Thousand SEK | -81.79% |
| 2017 Q4 | -479 Thousand SEK | -514.1% |
| 2017 Q3 | -78 Thousand SEK | 85.47% |
| 2016 Q4 | 499.71 Thousand SEK | 0.0% |
| 2016 FY | - SEK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acarix AB (publ) | -77.55 Million SEK | -697.261% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 305.689% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 305.689% |
| Arcoma AB | 4.66 Million SEK | 13368.24% |
| Bactiguard Holding AB (publ) | -131.93 Million SEK | -368.647% |
| Boule Diagnostics AB (publ) | 39.27 Million SEK | 1674.484% |
| CellaVision AB (publ) | 167.05 Million SEK | 470.126% |
| Clinical Laserthermia Systems AB (publ) | -65.93 Million SEK | -837.77% |
| Chordate Medical Holding AB (publ) | -29.57 Million SEK | -1990.859% |
| C-Rad AB (publ) | 44.24 Million SEK | 1497.478% |
| Duearity AB (publ) | -25.76 Million SEK | -2299.953% |
| Dignitana AB (publ) | -15.02 Million SEK | -4014.868% |
| Episurf Medical AB (publ) | -94.8 Million SEK | -552.215% |
| Getinge AB (publ) | 3.81 Billion SEK | 116.211% |
| Scandinavian Real Heart AB (Publ) | -68.44 Million SEK | -803.341% |
| Iconovo AB (publ) | -45.77 Million SEK | -1250.685% |
| Integrum AB (publ) | 6.51 Million SEK | 9594.283% |
| Luxbright AB (publ) | -25.8 Million SEK | -2296.099% |
| Mentice AB (publ) | -679 Thousand SEK | -90960.383% |
| OssDsign AB (publ) | -91.95 Million SEK | -572.387% |
| Paxman AB (publ) | 12.61 Million SEK | 4999.754% |
| Promimic AB (publ) | -9.11 Million SEK | -6681.092% |
| Qlife Holding AB (publ) | -168.69 Million SEK | -266.515% |
| SciBase Holding AB (publ) | -53.93 Million SEK | -1046.295% |
| ScandiDos AB (publ) | -13.48 Million SEK | -4485.775% |
| Sectra AB (publ) | 518.49 Million SEK | 219.25% |
| Sedana Medical AB (publ) | -65.54 Million SEK | -843.293% |
| Senzime AB (publ) | -133.74 Million SEK | -362.298% |
| SpectraCure AB (publ) | -21.35 Million SEK | -2795.883% |
| Stille AB | 44.95 Million SEK | 1475.467% |
| Vitrolife AB (publ) | -3.58 Billion SEK | 82.772% |
| Xvivo Perfusion AB (publ) | 38.5 Million SEK | 1705.724% |